Form 4: DiaMedica Therapeutics Director Richard Kuntz Acquires Shares Via Restricted Stock Units

Director Richard Kuntz acquired 9,925 shares of DiaMedica Therapeutics Inc. through a restricted stock unit award in lieu of cash retainer fees.

Summary

• On January 2, 2025, Richard Kuntz, a director of DiaMedica Therapeutics Inc., acquired 9,925 shares of the company's voting common stock.
• The acquisition was made through a restricted stock unit (RSU) award granted under the company's Amended and Restated 2019 Omnibus Incentive Plan.
• These shares are issuable upon the vesting and settlement of the RSU award, which was granted in lieu of $53,000 in cash retainer fees.
• The RSU award will vest in four nearly equal installments on March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025.
• The price per share for the acquisition is $5.34.
• Following the transaction, Kuntz beneficially owns 24,210 shares of DiaMedica Therapeutics Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects a standard transaction related to director compensation. The acquisition of shares by a director is generally viewed positively, but it's not a major event.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future prospects.
• The use of RSUs in lieu of cash retainer fees can conserve the company's cash resources.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the restricted stock units.

Industry Context

This type of transaction is common in the pharmaceutical industry, where stock options and RSUs are frequently used to compensate and incentivize executives and directors.

Comparison to Industry Standards

• Stock-based compensation is a standard practice among publicly traded companies, particularly in the biotech and pharmaceutical sectors.
• Companies like Amgen, Biogen, and Gilead Sciences also utilize stock options and RSUs as part of their compensation packages for directors and executives.
• The vesting schedule of the RSUs (quarterly installments) is a fairly typical arrangement.

Stakeholder Impact

• The transaction could have a slightly positive impact on shareholder sentiment, as it indicates a director's investment in the company.
• Employees may view the use of RSUs as a positive sign of the company's commitment to conserving cash.

Key Dates